Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Stereotactic body radiotherapy (SBRT) with functional treatment planning in patients with hepatocellular carcinoma (HCC) and advanced hepatic cirrhosis: Survival outcomes and toxicity.
Authors
Alexander V. Kirichenko
Department of Radiation Oncology, Allegheny Health Network Cancer Institute, Pittsburgh, PA
Alexander V. Kirichenko , Shaakir Hasan , Yun Liang , Danny Lee , Aishvarya Godla , Paul Renz , Stephen Abel , Tadahiro Uemura , Lorenzo Machado , Ngoc Thai
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Therapeutics
DOI
10.1200/JCO.2022.40.4_suppl.460
Abstract #
460
Poster Bd #
C10
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A phase I clinical trial of stereotactic body radiotherapy with atezolizumab and bevacizumab in advanced hepatocellular carcinoma.
First Author: Timothy J Brown
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Bridge-to-transplant stereotactic body radiation therapy in patients with hepatocellular carcinoma and advanced cirrhosis.
First Author: Mohammad Hissourou
Poster
2017 Gastrointestinal Cancers Symposium
Safety and efficacy of accelerated hypofractionation and stereotactic body radiotherapy for hepatocellular carcinoma in the setting of advanced liver dysfunction.
First Author: Nima Nabavizadeh
Poster
2015 Gastrointestinal Cancers Symposium
Evaluation of liver toxicity using Child-Pugh, MELD, and MELD-Na following stereotactic body radiation therapy (SBRT) of hepatocellular carcinomas.
First Author: Louis Lu